603 related articles for article (PubMed ID: 30572031)
21. Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Pelosi G; Haspinger ER; Bimbatti M; Leone G; Paolini B; Fabbri A; Tamborini E; Perrone F; Testi A; Garassino M; Maisonneuve P; de Braud F; Pilotti S; Pastorino U
Int J Surg Pathol; 2014 Apr; 22(2):136-48. PubMed ID: 24326823
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non-Small Cell Lung Carcinoma.
Parra ER; Villalobos P; Mino B; Rodriguez-Canales J
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):83-93. PubMed ID: 28719380
[TBL] [Abstract][Full Text] [Related]
23. Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.
Funkhouser WK; Hayes DN; Moore DT; Funkhouser WK; Fine JP; Jo H; Nikolaishvilli-Feinberg N; Eeva M; Grilley-Olson JE; Banks PM; Graziano P; Boswell EL; Elmberger G; Raparia K; Hart CF; Sholl LM; Nolan NJ; Fritchie KJ; Pouagare E; Allen TC; Volmar KE; Biddinger PW; Kleven DT; Papez MJ; Spencer DV; Rekhtman N; Mino-Kenudson M; Hariri L; Driver B; Cagle PT
Arch Pathol Lab Med; 2018 Dec; 142(12):1537-1548. PubMed ID: 29708428
[TBL] [Abstract][Full Text] [Related]
24. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
[TBL] [Abstract][Full Text] [Related]
25. A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma.
Tacha D; Yu C; Bremer R; Qi W; Haas T
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):201-7. PubMed ID: 22498669
[TBL] [Abstract][Full Text] [Related]
26. Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.
Büttner R; Gosney JR; Skov BG; Adam J; Motoi N; Bloom KJ; Dietel M; Longshore JW; López-Ríos F; Penault-Llorca F; Viale G; Wotherspoon AC; Kerr KM; Tsao MS
J Clin Oncol; 2017 Dec; 35(34):3867-3876. PubMed ID: 29053400
[TBL] [Abstract][Full Text] [Related]
27. Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas.
Conde E; Hernandez S; Prieto M; Martinez R; Lopez-Rios F
Expert Rev Mol Diagn; 2016 Jun; 16(6):707-13. PubMed ID: 27031368
[TBL] [Abstract][Full Text] [Related]
28. Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
Shiran I; Heller E; Jessel S; Kamer I; Daniel-Meshulam I; Navon R; Urban D; Onn A; Bar J
Clin Lung Cancer; 2017 May; 18(3):316-323.e1. PubMed ID: 28237243
[TBL] [Abstract][Full Text] [Related]
29. Roles of immunohistochemical staining in diagnosing pulmonary squamous cell carcinoma.
Yan Y; Zhang YX; Fang WF; Kang SY; Zhan JH; Chen N; Hong SD; Liang WH; Tang YN; He DC; Wu X; Zhang L
Asian Pac J Cancer Prev; 2015; 16(2):551-7. PubMed ID: 25684486
[TBL] [Abstract][Full Text] [Related]
30. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference.
Amin MB; Trpkov K; Lopez-Beltran A; Grignon D;
Am J Surg Pathol; 2014 Aug; 38(8):e20-34. PubMed ID: 25029121
[TBL] [Abstract][Full Text] [Related]
31. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
[TBL] [Abstract][Full Text] [Related]
32. The Use of a Novel Immunohistochemical Triple Cocktail in the Subclassification of Resected Non-Small Cell Lung Carcinomas: A Comparative Study With Morphology and Traditional Immunohistochemistry.
HooKim K; Chaudoir CS; Chaudhery SI; Reid MD
Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):27-34. PubMed ID: 27258567
[TBL] [Abstract][Full Text] [Related]
33. PD-L1 IHC in NSCLC with a global and methodological perspective.
Thunnissen E; de Langen AJ; Smit EF
Lung Cancer; 2017 Nov; 113():102-105. PubMed ID: 29110835
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 immunohistochemistry for non-small cell lung carcinoma: which strategy should be adopted?
Hofman P
Expert Rev Mol Diagn; 2017 Dec; 17(12):1097-1108. PubMed ID: 29069958
[TBL] [Abstract][Full Text] [Related]
35. Large cell carcinoma of the lung: a tumor in search of an author. A clinically oriented critical reappraisal.
Pelosi G; Barbareschi M; Cavazza A; Graziano P; Rossi G; Papotti M
Lung Cancer; 2015 Mar; 87(3):226-31. PubMed ID: 25620799
[TBL] [Abstract][Full Text] [Related]
36. Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.
Savic S; Diebold J; Zimmermann AK; Jochum W; Baschiera B; Grieshaber S; Tornillo L; Bisig B; Kerr K; Bubendorf L
Lung Cancer; 2015 Aug; 89(2):104-9. PubMed ID: 26056079
[TBL] [Abstract][Full Text] [Related]
37. Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?
Kerr KM; Tsao MS; Nicholson AG; Yatabe Y; Wistuba II; Hirsch FR;
J Thorac Oncol; 2015 Jul; 10(7):985-9. PubMed ID: 26134220
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry in the era of personalised medicine.
McCourt CM; Boyle D; James J; Salto-Tellez M
J Clin Pathol; 2013 Jan; 66(1):58-61. PubMed ID: 23002284
[TBL] [Abstract][Full Text] [Related]
39. EGFR-immunohistochemistry in colorectal cancer and non-small cell lung cancer: comparison of 3 commercially available EGFR-antibodies.
Buffet W; Geboes KP; Dehertogh G; Geboes K
Acta Gastroenterol Belg; 2008; 71(2):213-8. PubMed ID: 18720932
[TBL] [Abstract][Full Text] [Related]
40. Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.
Rossi G; Pelosi G; Barbareschi M; Graziano P; Cavazza A; Papotti M
Int J Surg Pathol; 2013 Aug; 21(4):326-36. PubMed ID: 23740564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
